Literature DB >> 12365958

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

F Xavier Castellanos1, Patti P Lee, Wendy Sharp, Neal O Jeffries, Deanna K Greenstein, Liv S Clasen, Jonathan D Blumenthal, Regina S James, Christen L Ebens, James M Walter, Alex Zijdenbos, Alan C Evans, Jay N Giedd, Judith L Rapoport.   

Abstract

CONTEXT: Various anatomic brain abnormalities have been reported for attention-deficit/hyperactivity disorder (ADHD), with varying methods, small samples, cross-sectional designs, and without accounting for stimulant drug exposure.
OBJECTIVE: To compare regional brain volumes at initial scan and their change over time in medicated and previously unmedicated male and female patients with ADHD and healthy controls. DESIGN, SETTING, AND PARTICIPANTS: Case-control study conducted from 1991-2001 at the National Institute of Mental Health, Bethesda, Md, of 152 children and adolescents with ADHD (age range, 5-18 years) and 139 age- and sex-matched controls (age range, 4.5-19 years) recruited from the local community, who contributed 544 anatomic magnetic resonance images. MAIN OUTCOME MEASURES: Using completely automated methods, initial volumes and prospective age-related changes of total cerebrum, cerebellum, gray and white matter for the 4 major lobes, and caudate nucleus of the brain were compared in patients and controls.
RESULTS: On initial scan, patients with ADHD had significantly smaller brain volumes in all regions, even after adjustment for significant covariates. This global difference was reflected in smaller total cerebral volumes (-3.2%, adjusted F(1,280) = 8.30, P =.004) and in significantly smaller cerebellar volumes (-3.5%, adjusted F(1,280) = 12.29, P =.001). Compared with controls, previously unmedicated children with ADHD demonstrated significantly smaller total cerebral volumes (overall F(2,288) = 6.65; all pairwise comparisons Bonferroni corrected, -5.8%; P =.002) and cerebellar volumes (-6.2%, F( 2,288) = 8.97, P<.001). Unmedicated children with ADHD also exhibited strikingly smaller total white matter volumes (F(2,288) = 11.65) compared with controls (-10.7%, P<.001) and with medicated children with ADHD (-8.9%, P<.001). Volumetric abnormalities persisted with age in total and regional cerebral measures (P =.002) and in the cerebellum (P =.003). Caudate nucleus volumes were initially abnormal for patients with ADHD (P =.05), but diagnostic differences disappeared as caudate volumes decreased for patients and controls during adolescence. Results were comparable for male and female patients on all measures. Frontal and temporal gray matter, caudate, and cerebellar volumes correlated significantly with parent- and clinician-rated severity measures within the ADHD sample (Pearson coefficients between -0.16 and -0.26; all P values were <.05).
CONCLUSIONS: Developmental trajectories for all structures, except caudate, remain roughly parallel for patients and controls during childhood and adolescence, suggesting that genetic and/or early environmental influences on brain development in ADHD are fixed, nonprogressive, and unrelated to stimulant treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365958     DOI: 10.1001/jama.288.14.1740

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  386 in total

Review 1.  Interface between neurology and psychiatry in childhood.

Authors:  Gillian Baird; Paramala J Santosh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

Review 2.  Early pathogenic care and the development of ADHD-like symptoms.

Authors:  Brigitte Dahmen; Vanessa Pütz; Beate Herpertz-Dahlmann; Kerstin Konrad
Journal:  J Neural Transm (Vienna)       Date:  2012-06-02       Impact factor: 3.575

3.  Comparison of brain volume abnormalities between ADHD and conduct disorder in adolescence.

Authors:  Michael C Stevens; Emily Haney-Caron
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

Review 4.  The use of &#x03B1;-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

5.  Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.

Authors:  L J S Schweren; C A Hartman; M P Zwiers; D J Heslenfeld; D van der Meer; B Franke; J Oosterlaan; J K Buitelaar; P J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-14       Impact factor: 4.785

6.  Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory.

Authors:  Shirley Y Hill; Sarah Lichenstein; Shuhui Wang; Howard Carter; Michael McDermott
Journal:  Adv J Mol Imaging       Date:  2013-10-01

7.  Subcortical differences among youths with attention-deficit/hyperactivity disorder compared to those with bipolar disorder with and without attention-deficit/hyperactivity disorder.

Authors:  Melissa Lopez-Larson; Emily S Michael; Janine E Terry; Janis L Breeze; Steven M Hodge; Lena Tang; David N Kennedy; Constance M Moore; Nikos Makris; Verne S Caviness; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

8.  Motor coordination problems in children and adolescents with ADHD rated by parents and teachers: effects of age and gender.

Authors:  E Fliers; N Rommelse; S H H M Vermeulen; M Altink; C J M Buschgens; S V Faraone; J A Sergeant; B Franke; J K Buitelaar
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

Review 9.  The neurobiological profile of girls with ADHD.

Authors:  E Mark Mahone; Ericka L Wodka
Journal:  Dev Disabil Res Rev       Date:  2008

10.  Brain structure mediates the association between socioeconomic status and attention-deficit/hyperactivity disorder.

Authors:  Laura Machlin; Katie A McLaughlin; Margaret A Sheridan
Journal:  Dev Sci       Date:  2019-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.